The type classification further refines the market taxonomy into flexible endoscopes, rigid endoscopes, capsule endoscopes and emerging hybrid systems. Flexible endoscopes dominate with an estimated 55% share, reflecting their versatility across gastrointestinal, respiratory and urological procedures and the extensive accessory ecosystem they support. Rigid endoscopes, contributing about 25%, are preferred in otolaryngology, arthroscopy and certain urologic surgeries where high‑definition optics and robust instrumentation are essential. Capsule endoscopes, a niche yet rapidly expanding segment at roughly 10%, leverage ingestible technology for non‑invasive visualization of the small intestine, driven by patient comfort and diagnostic yield improvements. Hybrid systems, integrating flexible shafts with robotic articulation, occupy the remaining 10% and are gaining traction in complex therapeutic and surgical workflows. This typology delineates distinct revenue streams, R&D investment priorities, and supply‑chain considerations that collectively determine the market's aggregate valuation.